IP Library Granted Patent US 7,066,962
Granted Patent B2
US 7,066,962 · App. 10/334,151 · Granted Jun 27, 2006

Composite surgical implant made from macroporous synthetic resin and bioglass particles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,066,962
App. No.
10/334,151
Granted
Jun 27, 2006
Kind
B2
Abstract

A cranio-maxillofacial implant material that is made of a macroporous (greater than 100 microns in diameter) interconnecting porous polyethylene structure with bioactive glass particles dispersed throughout the porous polyethylene structure, is disclosed. The Implant provides augmentation or replacement of cranio-maxillofacial tissues when implanted subperiosteally or within cranio-maxillofacial soft tissue. The addition of the bioactive glass particles to the porous polyethylene implant structure provides for faster fibrovascular ingrowth into the implant material.

Claims (20)

1. A porous surgical implant material for replacing or augmenting tissue in the body comprising a composite material made of an interconnected omni-directional porous matrix structure comprised of synthetic resin and bioactive glass particles distributed throughout said matrix

wherein said porous matrix structure is formed by sintering together a plurality of synthetic resin fines and wherein said bioactive glass particles remain separate and distinct and are not sintered together during said sintering process.

2. The porous surgical implant material as recited in claim 1 further wherein said porous matrix has a porosity that permits vascularization and tissue ingrowth.

3. The porous surgical implant material as recited in claim 1 wherein said porous matrix has a porosity of approximately 100 to 500 microns.

4. The porous surgical implant material as recited in claim 1 wherein the pore volume is approximately 40 to 60 percent.

5. The porous surgical implant material as recited in claim 1 wherein said bioactive glass particles comprise silicon dioxide, sodium oxide, calcium and phosphorus oxide.

6. The porous surgical implant material as recited in claim 5 wherein said bioactive glass particles comprise approximately 45% silicon dioxide, 45% sodium oxide, and the remaining 10% calcium and phosphorus oxide.

7. The porous surgical implant material as recited in claim 1 wherein said synthetic resin comprises polyethylene.

8. The porous surgical implant material as recited in claim 7 , wherein the matrix is characterized by a pore volume of 40% to 60%.

9. The porous surgical implant material as recited in claim 1 , wherein the matrix comprises 1–50% bioglass.

10. The porous surgical implant material as recited in claim 1 , wherein the matrix comprises 10–20% bioglass.

11. The porous surgical implant material as recited in claim 7 , wherein the matrix comprises 1–50% bioglass.

12. The porous surgical implant material as recited in claim 7 , wherein the matrix comprises 10–20% bioglass.

13. The porous surgical implant material as recited in claim 9 wherein said bioactive glass particles comprise silicon dioxide, sodium oxide, calcium and phosphorus oxide.

14. The porous surgical implant material as recited in claim 13 , which is characterized by a pore volume of 40–60%.

15. The porous surgical implant material as recited in claim 1 wherein said matrix structure is flexible.

16. A porous surgical implant material for replacing or augmenting tissue in the body comprising a composite material made of an interconnected omni-directional porous matrix structure comprised of synthetic resin and bioactive glass particles distributed throughout said matrix and said matrix structure of said implant is formed in the absence of a poragenic material and wherein said porous matix is formed by the sintering of synthetic resin fines together.

17. The porous surgical implant material as recited in claim 16 where said synthetic resin fines comprise polyethylene.

18. The porous surgical implant material as recited in claim 16 further wherein said porous matrix has a porosity that permits vascularization and tissue ingrowth.

19. The porous surgical implant material as recited in claim 16 further wherein said porous matrix is macroporous.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2012
From: HOWMEDICA OSTEONICS CORP.
To: ORTHOVITA, INC.
Reel/Frame 029582/0418 →